Mohamed Fouad Elsayed Khalil
Overview
Explore the profile of Mohamed Fouad Elsayed Khalil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeinhom M, Elsayed Khalil M, Omar Youssif T, Ali Daabis A, Almoataz M, Refat H, et al.
J Clin Neurosci
. 2025 Feb;
135:111156.
PMID: 40020561
Although topiramate and valproate are antiseizure medications that have many contraindications and could produce many side effects, they are still used as migraine preventive therapy in middle- and low-income countries....
2.
Zeinhom M, Ahmed S, Kohail A, Mohamed Kamel I, Abdelrahman A, Al-Nozha O, et al.
Sci Rep
. 2024 Nov;
14(1):29822.
PMID: 39616189
Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third...
3.
Ahmed S, Nahas N, Elsayed Khalil M, ElBassiouny A, Almoataz M, Omar T, et al.
CNS Drugs
. 2024 Nov;
39(1):81-93.
PMID: 39520630
Background: Many studies evaluated the efficacy and safety of ticagrelor versus clopidogrel in patients with ischemic stroke; none of these trials included North African participants, and all of these trials...
4.
Zeinhom M, Elsayed Khalil M, Mohamed Kamel I, Kohail A, Ahmed S, ElBassiouny A, et al.
Sci Rep
. 2024 Mar;
14(1):5960.
PMID: 38472241
Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third...